Leadership

• Executive Team

  
  

  

  

  • 
  • 
  • 
  • 
  • 
  • 
  • 
  • 

  • 

    Lee Valenta

    Lee Valenta is the president of Life Sciences for OptumInsight. In this role, Valenta leads the global operations that assist pharmaceutical, biotechnology, and medical device clients in identifying, analyzing, and measuring the value of their products. OptumInsight Life Sciences includes hundreds of expert professionals worldwide and has operations in North America, Europe, the Middle East, Africa, Latin America, and the Asia/Pacific region.  Read more >
  • 

    Peter Martin

    Peter Martin brings more than 10 years of operational experience to the Life Sciences division, where he leads a team dedicated to establishing and optimizing day-to-day operations. Prior to his role as COO, he was vice president of operations and chief of staff to the COO at OptumInsight (formerly Ingenix) and was responsible for leading various strategic and operational excellence initiatives.  Read more >
  • 

    Darryl Wills

    Darryl Wills is our chief growth officer responsible for formulating, managing, and implementing the strategies required to stimulate growth and streamline operations to optimize resources and maximize sales revenue and profitability. With nearly 25 years of expertise building business development and leading solution sales teams focused on portfolio solutions, Darryl is well-respected among his clients and colleagues for building strong client relationships.  Read more >
  • 

    William H Crown

    Bill Crown is group president of health economics and outcomes research and late phase research for OptumInsight. From 1982 to 1995, he was a faculty member at the Florence Heller Graduate School, Brandeis University, where he taught graduate courses in statistics and conducted research on the economics of aging and long-term care policy. Bill is the author or co-author of four books and more than 90 referenced journal articles, b  ook chapters, and other publications.  Read more >
  • 

    Brian Kelly

    Brian Kelly runs a number of global P&Ls for OptumInsight’s life sciences group, each centered around developing, proving, and improving the value proposition for pharmaceutical, biologic, and medical device interventions. He has spent more than 15 years in the pharmaceutical and device industries with experience that includes global operating responsibility for Covance’s central laboratories and serving as vice president of research planning at Merck and Co.  Read more >
  • 

    Gus Gardner

    Gus Gardner has over 21 years of senior management experience across several sectors of health care. As group president of QualityMetric, the patient insights consultancy of OptumInsight’s life sciences group, Gus is tasked with the day-to-day operations of QualityMetric’s commercial business unit and chartered with translating the company’s visions and strategies into viable business tactics, effective operational processes, and scalable methods.  Read more >
  • 

    Tracy Ken Tsuetaki

    Tracy Tsuetaki is group president of regulatory affairs and safety for OptumInsight’s life sciences group. Previously, he was group president of clinical development services for i3 Research. He has also served as chief marketing officer at Covance, Inc., group president at Catalent Pharma Solutions, and president of the medical communications and consulting division of Quintiles Transnational.  Read more >
  • 

    Nina Pruitt

    Nina Pruitt serves as head of our global marketing team, shaping the life sciences marketing strategy for the health ecosystem. With nearly 25 years of life sciences brand and direct response marketing expertise, Nina brings together various stakeholder perspectives to shape marketing strategy.  Read more >